(Q39861719)

English

PCA3 urine mRNA testing for prostate carcinoma: patterns of use by community urologists and assay performance in reference laboratory setting

scientific article published on 8 November 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

PCA3 urine mRNA testing for prostate carcinoma: patterns of use by community urologists and assay performance in reference laboratory setting (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

prostate carcinoma

1 reference

based on heuristic

inferred from title

author name string

Scott B Shappell

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

John Fulmer

2

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

David Arguello

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Brian S Wright

4

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Jonathan R Oppenheimer

5

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Mathew J Putzi

6

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

language of work or name

0 references

publication date

8 November 2008

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

73

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

363-368

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Screening for prostate cancer: current recommendations

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.459

7 January 2021

Screening for prostate cancer: opportunities and challenges

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.459

7 January 2021

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.459

7 January 2021

DD3PCA3 RNA analysis in urine--a new perspective for detecting prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.459

7 January 2021

uPM3, a new molecular urine test for the detection of prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.459

7 January 2021

APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.459

7 January 2021

The time-resolved fluorescence-based PCA3 test on urinary sediments after digital rectal examination; a Dutch multicenter validation of the diagnostic performance

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.459

7 January 2021

PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.459

7 January 2021

PCA3: a molecular urine assay for predicting prostate biopsy outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.459

7 January 2021

PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.459

7 January 2021

Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.459

7 January 2021

Significance of atypical and suspicious small acinar proliferations, and high grade prostatic intraepithelial neoplasia on prostate biopsy: implications for cancer detection and biopsy strategy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.459

7 January 2021

When to biopsy and when to stop biopsying

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.459

7 January 2021

Prostate biopsy strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.459

7 January 2021

Pathological Features After Radical Prostatectomy in Potential Candidates for Active Monitoring

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.459

7 January 2021

Identification of PCA3 (DD3) in prostatic carcinoma by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.08.459

7 January 2021

Identifiers

10.1016/J.UROLOGY.2008.08.459

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39861719&oldid=2091675835"